乐观
$410.08
情景价格
$295.780
-1.538 (-0.52%)收盘时
UFP Technologies, Inc. is a designer and custom manufacturer of solutions for medical devices, sterile packaging, and other engineered custom products. The Company’s single-use and single-patient devices and components are used in a range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants. Its manufacturing operations consist primarily of cutting, routing, compression and injection molding, vacuum-forming, micro-molding, thermoforming, laminating, radio frequency and impulse welding, and assembling. It also engineers components for automotive use in interior trim and structural applications. These components are produced using a compression molding process to create functional composites consisting of various materials such as polypropylene/fiberglass panels, nonwovens, and fabrics. It also develops and manufactures precision thermo-formed and heat-sealed polymer components.
UFP Technologies Inc is a good buy right now due to its strong earnings growth and positive momentum. The current price is $295.78, and the company reported a 15.1% year-over-year increase in sales for Q2 2026, reaching $174 million. Additionally, the forward P/E ratio is 21.83, suggesting the stock is reasonably valued relative to its growth prospects. However, insider selling activity is a concern, with a director selling 1,000 shares recently, which may indicate profit-taking. The main risk is the hedge fund selling activity, which has increased by 2780% over the last quarter, potentially signaling bearish sentiment among institutional investors.
Lake Street
$289
2025-08-06
Lake Street
2025-08-06
目标价
$289
Raymond James
—
2025-03-28
Raymond James
2025-03-28
目标价
—
Lake Street
$392
2024-07-17
Lake Street
2024-07-17
目标价
$392
Lake Street
$344
2024-07-02
Lake Street
2024-07-02
目标价
$344
Lake Street
$300
2024-06-28
Lake Street
2024-06-28
目标价
$300
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

UFP Technologies Director Sells Shares Amid Strong Stock Performance

UFP Technologies Director Sells Shares Amid Stock Surge

UFP Technologies to Present at Midwest IDEAS Investor Conference

UFP Technologies (UFPT) Q2 2026 Earnings Call Transcript

UFP Technologies Reports Strong Q2 2026 Earnings Growth
UFP Technologies, Inc. is a designer and custom manufacturer of solutions for medical devices, sterile packaging, and other engineered custom products. The Company’s single-use and single-patient devices and components are used in a range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants. Its manufacturing operations consist primarily of cutting, routing, compression and injection molding, vacuum-forming, micro-molding, thermoforming, laminating, radio frequency and impulse welding, and assembling. It also engineers components for automotive use in interior trim and structural applications. These components are produced using a compression molding process to create functional composites consisting of various materials such as polypropylene/fiberglass panels, nonwovens, and fabrics. It also develops and manufactures precision thermo-formed and heat-sealed polymer components. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).
UFP Technologies Inc is a good buy right now due to its strong earnings growth and positive momentum. The current price is $295.78, and the company reported a 15.1% year-over-year increase in sales for Q2 2026, reaching $174 million. Additionally, the forward P/E ratio is 21.83, suggesting the stock is reasonably valued relative to its growth prospects. However, insider selling activity is a concern, with a director selling 1,000 shares recently, which may indicate profit-taking. The main risk is the hedge fund selling activity, which has increased by 2780% over the last quarter, potentially signaling bearish sentiment among institutional investors.
1 analysts cover UFPT: 1 rate it Buy, 0 Hold and 0 Sell.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。